PMI U.S. BRINGS TECHNOVATION TO WASHINGTON D.C.

Core Viewpoint - The U.S. launch of PMI's Technovation platform represents a significant step towards advancing smoke-free alternatives and fostering collaboration among various stakeholders to promote a smoke-free future in the United States [2][4]. Group 1: Technovation Event - Technovation will debut on April 14, 2026, in Washington D.C., gathering experts, policymakers, and business leaders to discuss innovation and regulation in the smoke-free sector [1][4]. - The event aims to present new data on the U.S. adult smoking population and address challenges such as misconceptions about nicotine and the need for collaboration against illicit trade [4]. Group 2: PMI's Commitment and Investments - PMI has invested over $16 billion since 2008 in developing smoke-free products, which are now used by over 43 million legal-age consumers globally [5][8]. - The company is expanding its U.S. manufacturing capabilities, with facilities in Aurora, Colorado; Owensboro, Kentucky; and Wilson, North Carolina, and has grown its workforce from several hundred to over 3,000 employees [2][6]. Group 3: Smoke-Free Product Portfolio - PMI's smoke-free portfolio is anchored by ZYN, the leading smoke-free product in the U.S. and the first nicotine pouch authorized by the FDA [3][5]. - The smoke-free business accounted for 41.5% of PMI's total net revenues for the full year 2025, highlighting the company's focus on transitioning consumers to better alternatives [8]. Group 4: Regulatory and Market Position - PMI holds 80% of modified risk tobacco product authorizations and 41% of premarket tobacco product application marketing orders issued by the FDA, underscoring its leadership in scientific advancement and product innovation [5][8]. - The company is committed to responsible marketing practices and aims to provide approximately 30 million legal-age smokers with better smoke-free alternatives [6].